Lichen Planopilaris research hub

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

This study is testing a new medicine, brepocitinib, for a hair loss condition called lichen planopilaris (LPP). Researchers want to see if it's safe and helps improve symptoms. It's for adults with active LPP and involves taking tablets or a dummy pill.